Michael A. Panzara - May 24, 2024 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
/s/ Mark Worthington, Attorney in fact for Michael A. Panzara
Stock symbol
ATHA
Transactions as of
May 24, 2024
Transactions value $
$0
Form type
4
Date filed
5/24/2024, 06:56 PM
Previous filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +20.9K $0.00 20.9K May 24, 2024 Common Stock 20.9K $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of (i) May 24, 2025, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 24, 2024. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.